Aliya Medcare Finance, LLC v. Nickell

156 F. Supp. 3d 1105, 2015 WL 9695307
CourtDistrict Court, C.D. California
DecidedMay 26, 2015
DocketCASE NO. CV 14-07806 MMM (SHx)
StatusPublished
Cited by3 cases

This text of 156 F. Supp. 3d 1105 (Aliya Medcare Finance, LLC v. Nickell) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Aliya Medcare Finance, LLC v. Nickell, 156 F. Supp. 3d 1105, 2015 WL 9695307 (C.D. Cal. 2015).

Opinion

ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS’ MOTION TO DISMISS

MARGARET M. MORROW, UNITED STATES DISTRICT JUDGE

On October 8, 2014, Aliya Medcare Finance, LLC (“Aliya”) filed, this action against Robert P. Nickell, Comprehensive Toxicology Billing, LLC (“CTB”), Exec Billing Services, LLC (“Exec Billing”) (collectively “defendants”), and various fictitious defendants.1 The complaint alleged eleven claims arising from a dispute concerning negotiation and implementation of a factoring agreement between Aliya and defendants. On November 20, 2014, Aliya filed an ex parte application for a temporary restraining order.2 It sought a temporary restraining order requiring defendants to (1) transfer to Aliya all funds received to date as payment on receivables Aliya had purchased from CTB; (2) continue to transfer to Aliya, until the conclusion of a trial on the merits, all funds received as payment on receivables Aliya had purchased from CTB; (3) give Aliya any and all documentation received concerning receivables it had purchased; (4) give Aliya access to the billing and collection software used to manage and collect the receivables it had purchased from CTB; and restraining defendants from (5) managing, controlling, collecting, or taking any action with respect to receivables Aliya had purchased from CTB except as provided in items (1)-(4) above.3 On November 26, 2015, the court denied Aliya’s application because it had not adequately shown that it would suffer imminent, irreparable harm if an injunction were not entered.4

On December 18, 2014, Aliya filed a first amended complaint.5 The first amended complaint alleges eleven claims.6 It pleads claims against Nickell and CTB for fraud in the inducement of the factoring agree[1111]*1111ment; fraudulent concealment; promissory fraud; negligent misrepresentation; and conversion.7 It also alleges separate breach of contract claims against CTB and Exec Billing;8 intentional interference with contractual relations and violation of California Business and Professions Code § 17200 claims against Niekell; and claims for an accounting and imposition of a constructive trust against all defendants.

On December 29, 2014, the court approved the parties’ stipulation to extend defendants’ time to respond to the first amended complaint to January 30, 2015.9 On January 30, 2015, defendants filed a motion to dismiss the first through fourth and sixth through tenth claims in Aliya’s first amended complaint; they do not seek dismissal of Aliya’s fifth claim for breach of contract against CTB or eleventh claim for an accounting.10 Aliya opposes the motion.11

I. FACTUAL BACKGROUND

Aliya is in the business of factoring.12 The complaint alleges that Niekell is a successful pharmacist and businessman who owns and controls multiple undercapi-talized shell entities through which he conducts a multimillion dollar medical services business.13 One such entity is CTB, which provides toxicology services — specifically urinalysis — to patients with workers’ compensation claims. As relevant here, instead of charging patients directly for toxicology services, CTB allegedly invoices an insurance company that provides coverage for the services.14 The right to receive payments from insurance providers is purportedly a receivable that is often marketed and sold to third parties that factor receivables.15 CTB has allegedly originated thousands of such receivables,. each of which typically represents a bill of $800 to $1,400.16

A. The Factoring, Non-Compete, and Indemnification Agreements

Beginning in the fourth quarter of 2012 and continuing to the first quarter of 2013, CTB and Aliya allegedly entered into three factoring agreements pursuant to which Aliya purchased existing CTB receivables and an exclusive right to acquire all right, title, and interest to CTB’s future receivables for a period of five years.17 [1112]*1112The first agreement, which was executed in November 2012, documented Aliya’s purchase of $7.9 million of CTB’s receivables; 18 the second agreement, which was executed in February 2013, reflected Ali-ya’s purchase of $4.1 million of CTB’s receivables,19 while the third agreement, executed in March 2013, documented Aliya’s purchase of $18 million of CTB’s receivables.20 The third agreement also gave Aliya the exclusive right to purchase all of CTB’s future receivables for five years, or until January 2018.21 Aliya asserts that by entering into these agreements, it acquired the right to receive all payments made on all of CTB’s then-existing receivables as well as all future receivables through January 2018.22

Aliya alleges that, to induce it to enter into the third agreement and pay in excess of $4 million for the receivables being purchased, Niekell executed and delivered a covenant not to compete and a covenant to indemnify.23 The non-competition clause purportedly required all entities affiliated with CTB (the “Niekell entities”), including Exec Billing, to acknowledge that they and their respective managers, including Nic-kell, would conduct all toxicology business solely through CTB' — for Aliya’s benefit— and ensure that they operated in such a way that all receivables generated were subject to the third agreement.24 In the indemnification clause, the Niekell entities allegedly promised to indemnify Aliya for any loss caused by CTB’s breach of the third agreement.25

Aliya, for its part, agreed to purchase all of CTB’s receivables without conducting any due diligence; in exchange, it negotiated a provision that permitted it to return any and all receivables that failed to meet certain criteria.26 Thus, section 14 of the third agreement provided that Aliya “shall have the right, at any time, to reject any [Receivable that, in [Aliya’s] judgment, meet or includes one or more of the following criteria... ,”27 The criteria set forth in section 14, for example, permitted Aliya to reject receivables that represented claims or charges “requested by a physician of record that [are] not within the applicable ‘Medical Provider Network’ [ (“MPN”) ],” i.e., claims presented by out-of-network providers.28 Section 14 also provided that if Aliya rejected a receivable based on any of the enumerated criteria, CTB would “have the opportunity to object to [Ailya’s] classification of [the] [receivable as [rejectable] within 10 days of receiving notice thereof[;] ... the parties [ ] agree[d] to make a ‘good faith effort to mutually determine whether the cause of such [Receivable becoming [rejectable] [could] be cured by [CTB] within a commercially reasonable time.” “With respect to any [Rejected [Receivable that [as to which CTB could not cure], an amount equal to the applicable [p]urchase [p]rice ... [was to] be deducted from the immedi[1113]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
C.D. California, 2026
Rittmann v. Amazon.com Inc
W.D. Washington, 2024
Bungie Inc v. L.L.
W.D. Washington, 2023

Cite This Page — Counsel Stack

Bluebook (online)
156 F. Supp. 3d 1105, 2015 WL 9695307, Counsel Stack Legal Research, https://law.counselstack.com/opinion/aliya-medcare-finance-llc-v-nickell-cacd-2015.